Guide · 7 min

Why Your Run Feels Harder in Pollen Season (And What to Do About It)

If hayfever is slowing you down outdoors, your lungs might be picking up more than you think

By HaeloEvidence: moderate

In short

Prolonged outdoor exercise significantly amplifies pollen exposure in athletes due to substantially elevated ventilation rates (50-100 L/min vs. 6-8 L/min at rest) and a shift to oral breathing, increasing allergen deposition in the lower airways and exacerbating allergic rhinitis symptoms.

The part hayfever doesn't advertise

For most people, hayfever is a nose-and-eyes problem: the sneezing, the itch, the foggy head that makes May and June feel like wading through treacle. What's less talked about is what happens when pollen exposure isn't occasional — when it's relentless, cumulative, and happening while your lungs are working hardest. For outdoor workers, endurance athletes, and children sitting in classrooms with windows open, hayfever isn't just an inconvenience. It's a condition with a trajectory.

This article pulls together evidence on three groups who experience pollen exposure at higher intensities than most: people whose jobs keep them outside, people who train outdoors, and children at school during peak season. The science isn't yet complete — the gaps are real and worth naming honestly — but what we do know is specific enough to act on.


The science

Outdoor work: more hours, higher dose

Farmers, gardeners, and construction workers spend substantially more time in ambient pollen than the general population, and surveys confirm this translates into greater sensitisation and heavier symptom burdens. A perception-based survey of gardeners (Goyal, Ravindra & Mor, 2022) found that prolonged pollen contact was the dominant driver of allergic rhinitis severity in that group, while a systematic review and meta-analysis by Berezhanskiy et al. (2025) confirmed that pollen exposure is a consistent risk factor for allergic disease across occupational cohorts.

The biology runs through the same pathway as in any hayfever sufferer, but with the volume turned up. Inhaled pollen is processed by dendritic cells in the airway mucosa, triggering IgE-mediated mast cell activation and a Th2-skewed immune response — the cellular machinery of allergy. What makes outdoor occupational exposure distinctive is the co-presence of amplifiers: diesel exhaust particles and other traffic-related air pollutants enhance dendritic cell uptake of allergens and potentiate airway inflammation, a finding supported by Annesi-Maesano et al. (2023) in the context of asthma exacerbation risk from pollen-pollutant interactions.

There is, however, a genuine paradox in farming populations. The same endotoxin-rich environments that deliver high allergen loads may, in some individuals, activate innate immune pathways that partially dampen IgE sensitisation — the biological logic behind the 'farm effect' in allergy research. A five-year follow-up by Spierenburg et al. (2017) found that occupational endotoxin exposure had complex, subgroup-dependent associations with atopic outcomes in adults, neither uniformly harmful nor protective. This complexity matters: it means blanket statements about 'outdoor work causes worse hayfever' are too simple, even if the average signal points that way.

Athletes: the ventilation multiplier

At rest, you breathe around 6–8 litres of air per minute. During intense endurance exercise, that figure rises to 50–100 litres per minute. For a sensitised athlete running in a park during peak grass pollen season, that isn't a small difference — it's a fundamentally different exposure event.

A systematic review by Surda, Walker & Putala (2017) found rhinitis prevalence among athletes ranging from 27% to 74% across study populations. More precisely, a meta-analysis of 26 studies found that each 10 grains/m³ increase in ambient pollen concentration raised lower respiratory symptom risk by approximately 2% and upper and ocular symptom burden by 7–11% — effects that are amplified in athletes simply because they spend more hours outside and inhale more air per hour.

The mechanism compounds this dose problem in a specific way. During vigorous exercise, most people shift from nasal to oral breathing. The nose is a remarkable filter — its mucociliary architecture traps a large fraction of inhaled particles. The mouth is not. Studies suggest that bypassing nasal filtration allows an estimated 20–50% more pollen particles to reach the bronchi, where sensitised individuals have IgE-primed mast cells waiting. A cross-sectional study in German athletes (Salem et al., 2019) found that pollen-induced allergic rhinitis measurably impaired sports performance through nasal congestion, sleep disruption, and exercise-induced bronchoconstriction — a condition where the airways narrow during or after exercise.

This last point deserves attention. Exercise-induced bronchoconstriction (EIB) can occur in people who have never been diagnosed with asthma. In atopic individuals, the 'united airway model' — supported by mechanistic evidence across multiple research groups — proposes that Th2-driven inflammation originating in the nose doesn't stay there. IL-5-mediated eosinophil recruitment, leukotrienes, and systemic IgE priming can extend the inflammatory territory downward, particularly when exercise-driven airway drying and cooling are added to a pollen-loaded environment.

No study has yet established a precise pollen threshold above which a previously upper-airway-only rhinitis sufferer will develop lower-airway symptoms during training. The closest signal in the literature — from an infant cohort (Usemann et al.) — suggests lower respiratory effects begin appearing above roughly 10 grains/m³ of grass pollen at rest, implying the functional threshold for a ventilating adult may be considerably lower. The honest answer is that for sensitised athletes, there is probably no entirely safe pollen level during high-intensity training, only varying degrees of risk.

Predictive markers: what your body is trying to tell you

For athletes or outdoor workers with hayfever who want to know whether their lower airways are being quietly affected, one marker stands out from the available evidence: fractional exhaled nitric oxide, or FeNO.

FeNO is a breath test that measures nitric oxide produced by inflamed airway epithelium. Elevated levels (>25–50 ppb) reflect type 2 eosinophilic inflammation — the same cellular pattern seen in atopic asthma. Bonini et al. (2007) found FeNO to be the best-supported non-specialist predictor of atopic airway inflammation in elite athlete cohorts. Induced sputum eosinophils are more specific biologically, but require specialist referral and aren't practical for most people.

Peak flow variability — the daily high-low swing in how fast you can exhale — can document variable airflow obstruction, but performs poorly as a predictor of future asthma in this population and is easily confounded by effort and exertional physiology. It's a useful daily symptom diary, not a reliable early warning system on its own.

The critical caveat: allergic rhinitis itself elevates FeNO, so a raised reading doesn't automatically mean lower-airway disease is developing. No validated predictive model combining these markers exists for athletes with hayfever specifically. If you are an endurance athlete with hayfever and are noticing chest tightness, cough, or unusual breathlessness during or after sessions, that is the signal — not a test result alone — that warrants GP assessment and, potentially, a formal exercise challenge test.

Children: the academic cost of a blocked nose

In the context of 'occupational' exposure, school deserves its own section. A classroom during exam season is, for a hayfever-affected child, an environment of continuous low-grade physiological stress occurring precisely when cognitive demand is highest.

The evidence here is more consistent than in the occupational literature. Meta-analyses and multi-country cohort studies (including data from India, Nigeria, Spain, and Australia) converge on similar findings: children with allergic rhinitis miss approximately three times more school days than unaffected peers, and when present, experience roughly 37–42% impairment in classroom productivity (Blaiss, 2004; Mir, Panjabi & Shah, 2012). That's the equivalent of losing around one quarter of effective learning hours.

Two mechanisms compound each other here. First, nasal obstruction and nocturnal symptoms disrupt sleep architecture — affected children show approximately 2.5 times more sleep disturbances — producing the fatigue and slowed working memory that anyone who has tried to concentrate through a bad hayfever day will recognise. Second, first-generation antihistamines (the older, sedating type still used by many families) impose their own cognitive tax through anticholinergic and central nervous system effects, potentially making the treatment itself part of the problem during school hours.


What this means for you

If your job, training, or your child's school day involves sustained outdoor exposure during pollen season, hayfever isn't operating at the same intensity as a brief walk in the park. The cumulative dose is higher, the physiological context is more demanding, and the downstream risk — particularly of lower-airway involvement — is correspondingly greater.

This doesn't mean catastrophe. It means the management approach that's adequate for casual exposure may not be adequate for you.


The evidence landscape

It's worth being direct about confidence levels here. The evidence for occupational and athletic pollen exposure is largely observational — surveys, cross-sectional studies, and systematic reviews of heterogeneous cohorts. No randomised controlled trials have compared specific workplace accommodations against validated rhinitis outcomes. No longitudinal study has followed adults with isolated hayfever through an outdoor training programme with simultaneous pollen counts and objective lower-airway testing. The threshold question — how much is too much — remains genuinely unanswered.

The children's literature is somewhat stronger (multiple countries, larger samples, consistent effect estimates), but still relies heavily on proxy-reported productivity outcomes rather than standardised objective measures.

What the evidence does support with reasonable consistency: the direction of effect (more pollen exposure = worse outcomes for sensitised individuals), the mechanism of lower-airway risk during exercise, and the cognitive impact of uncontrolled rhinitis in school-age children. The precise magnitudes and the best intervention strategies are where the gaps remain.


What Haelo recommends

For outdoor workers (farmers, gardeners, construction)

  • Use your local pollen forecast to time high-exposure tasks — soil disturbance, mowing, crop handling — for late afternoon rather than morning, when pollen counts typically peak.
  • If your employer hasn't yet considered MERV 13+ HVAC filtration in indoor rest areas or offices, it's a reasonable accommodation to raise: the productivity case is well-documented (Vandenplas et al., 2017).
  • Take a non-sedating antihistamine (cetirizine, loratadine, fexofenadine) in the evening the night before high-exposure days — not as an afterthought when symptoms arrive. The 'stable door' principle: block the H1 receptors before the allergen arrives, not after.
  • If your job makes remote or indoor work impossible during peak season, intranasal corticosteroids (used daily, not on-demand) are the most evidence-supported pharmacological option for sustained occupational exposure.

For athletes and regular outdoor trainers

  • Check pollen counts before sessions and, where possible, schedule long or high-intensity runs and rides for early morning on lower-count days, or shift them indoors during peak season weeks.
  • On high-count days, don't just take an antihistamine — consider whether pre-exercise nasal corticosteroid use is appropriate (discuss with your GP, as timing and formulation matter).
  • Know the signs that your symptoms are moving lower: chest tightness that appears during or after exercise and resolves within 30–60 minutes, unusual post-session cough, or breathlessness disproportionate to your fitness level. These warrant a GP conversation — specifically mentioning exercise-induced bronchoconstriction.
  • If you track training load, also track pollen exposure on the same log. Patterns become visible over a season that aren't obvious day-to-day.

For parents of school-age children

  • Switch to a non-sedating antihistamine (second-generation: cetirizine, loratadine) if your child is currently using a first-generation one (chlorphenamine). The evidence on classroom cognitive impairment from sedating antihistamines is consistent enough to act on.
  • For children with moderate-to-severe rhinitis during exam periods, discuss a short course of intranasal corticosteroid with your GP — ideally starting 2–4 weeks before peak season, not mid-flare.
  • Inform the school. Most schools can offer simple accommodations — keeping windows closed during peak pollen hours, allowing children to take medication before travel rather than on arrival — but only if they know the context.
  • If sleep is visibly disrupted during pollen season, treat it as clinically relevant, not incidental. A tired child in an exam room is already behind.

Key references

See below.

The evidence

What the research actually says

Each answer below is drawn from a graded research review. Confidence reflects the strength of the underlying evidence, not how confident we feel about it.

How does occupational outdoor exposure affect hayfever severity in farmers, gardeners, and construction workers?

Occupational outdoor exposure in farmers, gardeners, and construction workers is associated with increased allergic rhinitis severity, primarily through prolonged contact with high concentrations of pollen, mold spores, and co-pollutants such as diesel exhaust particles. Evidence from surveys of gardeners, systematic reviews of agricultural workers, and European population cohorts consistently supports elevated sensitization and symptom burden in outdoor occupational groups compared to non-exposed individuals. However, direct quantitative comparisons between specific occupational groups (e.g., farmers vs. office workers) using validated AR outcome measures are largely absent from the current literature.

How it works

Outdoor occupational allergen exposure drives IgE-mediated Th2 immune responses, with co-exposures to diesel exhaust particles and endotoxins amplifying dendritic cell-mediated allergen uptake and airway inflammation; paradoxically, high-dose endotoxin exposure in farming contexts may also modulate atopic sensitization through innate immune pathways, potentially attenuating IgE responses in some subgroups.

Confidence: low

What evidence-based workplace accommodations exist for hayfever sufferers?

Evidence-based workplace accommodations for allergic rhinitis primarily include environmental modifications (HEPA/HVAC filtration, MERV 13+ filters, humidity control), telework/remote work policies, and scheduling adjustments to avoid peak allergen exposure periods. Systematic reviews confirm that uncontrolled rhinitis causes significant work productivity losses (20-30% reduction via WPAI scores), supporting the rationale for these accommodations, though direct RCT evidence for specific accommodation interventions remains sparse. Occupational rhinitis literature consistently recommends exposure reduction or removal as the cornerstone management strategy, with pharmacotherapy as an adjunct.

How it works

Airborne allergens (pollen, mold spores, occupational sensitizers) trigger IgE-mediated mast cell degranulation and Th2-driven mucosal inflammation in the nasal passages, causing nasal congestion, rhinorrhea, and cognitive impairment; reducing allergen load through filtration, ventilation, or physical removal from the exposure environment attenuates this inflammatory cascade and its downstream effects on work performance.

Confidence: low

How does prolonged outdoor exercise (athletes, runners) interact with pollen exposure and symptoms?

Prolonged outdoor exercise significantly amplifies pollen exposure in athletes due to substantially elevated ventilation rates (50-100 L/min vs. 6-8 L/min at rest) and a shift to oral breathing, increasing allergen deposition in the lower airways and exacerbating allergic rhinitis symptoms. Rhinitis prevalence among athletes ranges from 27-74% across systematic reviews, with pollen-induced allergic rhinitis shown to impair sports performance through nasal congestion, ocular irritation, sleep disruption, and exercise-induced bronchoconstriction. A meta-analysis of 26 studies found each 10 grains/m³ increase in pollen concentration raises lower respiratory symptom risk by approximately 2% and upper/ocular symptom burden by 7-11%, effects that are amplified in athletes due to greater cumulative outdoor exposure time.

How it works

During intense exercise, the obligatory shift to oral breathing bypasses nasal mucociliary filtration, allowing an estimated 20-50% more pollen particles to reach the bronchi, where they trigger mast cell degranulation and type 2 eosinophilic inflammation in sensitized individuals. Elevated minute ventilation further increases the total inhaled allergen dose in a dose-dependent manner, with polysensitized individuals showing measurable rises in FeNO (a marker of airway inflammation) proportional to pollen load.

Confidence: moderate

Do school-age children lose significant educational time to hayfever and what interventions help?

Children with allergic rhinitis miss approximately 3 times more school days than unaffected peers and, when present, experience roughly 37-42% impairment in classroom productivity, amounting to the loss of approximately one-quarter of effective academic hours. Beyond absenteeism, 'presenteeism' driven by nasal symptoms, sleep disruption (2.5x more disturbances), and medication side effects—particularly from sedating first-generation antihistamines—compounds academic underperformance, with lower grades observed during peak pollen seasons. Evidence from multiple countries (India, Nigeria, Spain, Australia) confirms this is a global phenomenon affecting approximately 1 in 5 school-age children.

How it works

AR-induced nasal obstruction, rhinorrhea, and nocturnal symptoms disrupt sleep architecture, producing secondary daytime fatigue, slowed cognitive processing, and impaired working memory that directly reduces learning capacity. First-generation antihistamines further exacerbate this through anticholinergic and sedating central nervous system effects, while complications such as eustachian tube dysfunction and conductive hearing loss create additional barriers to classroom learning.

Confidence: moderate

What proportion of adult-onset exercise-induced bronchoconstriction in atopic individuals is preceded by allergic rhinitis alone, without prior asthma diagnosis?

The exact proportion of adult-onset exercise-induced bronchoconstriction (EIB) in atopic individuals that is preceded exclusively by allergic rhinitis without prior asthma diagnosis is not quantified in the current literature. Available evidence confirms that allergic rhinitis is a strong atopic risk factor for EIB and that EIB can occur without a formal asthma diagnosis in roughly up to 20% of affected individuals, but no published cohort study stratifies adult-onset EIB cases by antecedent rhinitis-only history in the absence of prior asthma. Studies in pediatric rhinitis populations without asthma suggest EIB prevalence in that group is meaningful but contested, and direct extrapolation to adult-onset cases remains unsupported.

How it works

The unified airway model posits that Th2-skewed eosinophilic inflammation, IgE-mediated mast cell activation, and leukotriene release in allergic rhinitis can prime bronchial hyperresponsiveness through nasobronchial reflex arcs and systemic mediator spillover, predisposing atopic individuals to exercise-triggered bronchoconstriction via hyperventilation-induced airway cooling and drying. The atopic march framework further supports a progression in which shared epithelial barrier dysfunction (e.g., filaggrin variants) and persistent allergen sensitization drive sequential upper-to-lower airway involvement before a formal asthma diagnosis is established.

Confidence: insufficient

What threshold of cumulative outdoor pollen exposure correlates with first lower-airway symptoms in previously upper-airway-only allergic-rhinitis sufferers who train outdoors?

No empirically validated cumulative pollen threshold in grains/m³ has been established for the onset of first lower-airway symptoms in adults with previously upper-airway-only allergic rhinitis who train outdoors. Available evidence suggests a continuous, non-linear dose-response relationship with no truly symptom-free level for sensitized individuals; the closest quantitative signal comes from an infant cohort (Usemann et al. 2023) where lower respiratory symptoms began increasing detectably above ~10 grains/m³ of grass pollen at rest, implying the functional threshold in sensitized, exercising adults may be equal to or lower than this figure. Lower airway eosinophilic inflammation and bronchial hyperresponsiveness can be demonstrable at typical seasonal pollen levels even before spirometric changes or overt symptoms appear, and exercise amplifies this risk through hyperpnea-driven airway dehydration and mast-cell priming.

How it works

Seasonal pollen exposure in allergic rhinitis drives systemic type-2 inflammation (IL-4, IL-5, IL-13, eosinophilia) that traffics to bronchial mucosa via the 'united airway,' while nasobronchial autonomic reflexes from upper-airway allergen stimulation further increase bronchial smooth-muscle reactivity; superimposed exercise-induced airway hyperosmolarity and cooling then releases mast-cell mediators (histamine, leukotrienes) from an already IgE-primed, eosinophil-laden mucosa, lowering the threshold for bronchoconstriction below what either pollen or exercise would achieve alone.

Confidence: low

Which predictive markers (FENO, peak-flow variability, induced-sputum eosinophils) accessible without specialist referral predict asthma onset in adult endurance athletes with allergic rhinitis?

In adult endurance athletes with allergic rhinitis, FeNO is the best-supported non-specialist biomarker for identifying type 2 eosinophilic airway inflammation that may precede asthma onset, with values >25–50 ppb associated with atopic asthma phenotypes in athlete cohorts; induced sputum eosinophils (≥2–3%) provide the most biologically specific signal for eosinophilic inflammation but are logistically impractical outside specialist settings. Peak expiratory flow variability (>10% mean daily) can document variable airflow limitation but shows poor predictive performance for incident asthma in this population and is heavily confounded by effort, technique, and exertional physiology in athletes. Critically, no validated prospective model combining these three markers exists for predicting new-onset asthma specifically in adult endurance athletes with pre-existing allergic rhinitis; available evidence is largely cross-sectional and associative rather than predictive.

How it works

Allergic rhinitis drives IL-4/IL-13-mediated upregulation of inducible nitric oxide synthase in airway epithelium, elevating FeNO and promoting eosinophilic airway infiltration via united-airway inflammation that can extend from the upper to lower respiratory tract; repeated high-ventilation endurance exercise amplifies epithelial stress and allergen/irritant deposition, potentially accelerating the transition from upper-airway to lower-airway eosinophilic disease. However, high training loads can also induce neutrophilic or mixed airway inflammation independent of atopy, reducing the specificity of type 2 biomarkers for asthma prediction in this population.

Confidence: low

Where the evidence runs out

No occupation-stratified longitudinal studies exist that directly compare allergic rhinitis prevalence or validated symptom scores (e.g., total nasal symptom score) between farmers, gardeners, or construction workers and non-exposed controls; dose-response relationships between quantified occupational pollen/allergen exposure hours and AR severity outcomes remain uncharacterized for these specific groups. No high-quality RCTs directly measure the effectiveness of specific workplace accommodations (e.g., HEPA filtration, telework, scheduling changes) on validated rhinitis outcomes such as RQLQ scores, absenteeism rates, or presenteeism metrics in hayfever-specific populations. Most available evidence derives from cross-sectional productivity surveys, occupational case series, expert consensus panels, and legal/regulatory precedents rather than controlled interventional trials, leaving cost-effectiveness and comparative efficacy of individual accommodations largely unquantified. No longitudinal studies have directly quantified exercise-specific pollen dose using personal samplers during high-intensity athletic events (e.g., marathons, cycling races) or correlated those measurements with objective performance metrics such as race times or VO2 max. Existing evidence relies heavily on background pollen monitoring proxies rather than athlete-specific personal exposure data, and few studies disentangle exercise-induced rhinitis from allergic rhinitis in competitive athlete populations. Rigorous RCT-level evidence directly comparing specific pharmacological interventions (e.g., intranasal corticosteroids vs. non-sedating antihistamines vs. immunotherapy) on objectively measured educational outcomes—such as standardized test scores or attendance records—remains sparse, with most data relying on self-reported or proxy-reported productivity measures. School-based environmental intervention trials are largely absent, and stratified data by AR severity, allergen type, and socioeconomic context are insufficient to guide targeted policy recommendations. No prospective cohort studies enroll atopic adults with isolated allergic rhinitis, perform serial standardized exercise challenge testing, and report incident EIB as a primary endpoint in the absence of prior asthma, making a defensible numeric proportion impossible to derive. Future longitudinal studies should stratify by adult versus childhood onset, atopy phenotype, and prior asthma status to fill this critical epidemiologic gap, particularly given the domain relevance to occupational exposure settings where exercise demands and allergen loads are elevated. No prospective study has followed adults with isolated seasonal allergic rhinitis through an outdoor training program with simultaneous species-resolved daily pollen counts, quantified exercise load, and objective lower-airway endpoints (EIB testing, FeNO, sputum eosinophils), making it impossible to derive an individual or population-level cumulative dose threshold. Critical confounders—co-pollutant synergy (PM₂.₅, ozone), exercise intensity and duration, ambient temperature and humidity, and inter-individual variation in sensitization degree—remain uncontrolled in all existing datasets relevant to this question. There are no prospective cohort studies specifically tracking FeNO, PEF variability, or induced sputum eosinophils as predictors of incident asthma in adult endurance athletes with pre-existing allergic rhinitis, and the confounding effect of allergic rhinitis itself on FeNO elevation makes it difficult to distinguish upper-airway inflammation from emerging lower-airway disease without objective bronchial provocation testing. A validated multimarker risk model incorporating training load, environmental exposure (e.g., aquatic, cold-air), and type 2 biomarkers is entirely absent from the literature for this specific population.

Read the full evidence review

This article is general information about hayfever, not medical advice. It should not replace guidance from your GP, pharmacist or allergy specialist — particularly if you are pregnant, treating a child, or managing asthma alongside hayfever. Read our medical disclaimer.

Reading about it is one thing. Knowing your own season is another.

Haelo turns research like this into what to do today — based on your air, your patterns and your symptoms. Join the waitlist.

No spam. Unsubscribe any time. We'll only contact you about Haelo.